Similar Search Results

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data

Lichtenberg, Frank R.; Pettersson, Billie - 2012

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10009571756

Young innovative companies : the new high-growth firms?

Czarnitzki, Dirk; Delanote, Julie - 2012

Young Innovative Companies (YIC) gained increasing attention from governments and scholars due to their expected high innovative performance and growth. Consequently, this study investigates whether Young Innovative Companies, as defined by the EU, grow more than other firms, both in terms of...

Persistent link: https://www.econbiz.de/10009529671

Technologieakquisition und Marktstellung

Czarnitzki, Dirk; Kraft, Kornelius - In: Marktmacht, (pp. 27-48). 2010

Persistent link: https://www.econbiz.de/10009161200

Capital control, debt financing and innovative activity

Czarnitzki, Dirk; Kraft, Kornelius - In: Journal of economic behavior & organization : JEBO 71 (2009) 2, pp. 372-383

Persistent link: https://www.econbiz.de/10003873414

Incorporating innovation subsidies in the CDM framework : empirical evidence from Belgium

Czarnitzki, Dirk; Delanote, Julie - 2016 - This version: May 2016

Persistent link: https://www.econbiz.de/10011527417

Incorporating innovation subsidies in the CDM framework : empirical evidence from Belgium

Czarnitzki, Dirk; Delanote, Julie - 2016 - This version: May 2016

This paper integrates innovation input and output effects of R&D subsidies into a modified Crépon–Duguet–Mairesse (CDM …

Persistent link: https://www.econbiz.de/10011487998

Die Auswirkung der Forschungs- und Technologiepolitik auf die Innovationsaktivitäten ostdeutscher Unternehmen

Czarnitzki, Dirk - 2001 - Diese Version: Oktober 2001

impact of public technology policies on innovation of firms located in Eastern Germany. The main question is whether public … funding stimulates innovation activities or whether crowding-out effects between public and private means occur. A non … companies would have invested remarkably less if they had not participated in public innovation policy schemes. …

Persistent link: https://www.econbiz.de/10011445678

The effects of public R&D subsidies on firms' innovation activities : the case of Eastern Germany

Almus, Matthias; Czarnitzki, Dirk - 2002 - This version: August 2002

This study analyzes the effects of public R&D policy schemes on the innovation activities of firms located in Eastern … innovation activities by about four percentage points. …

Persistent link: https://www.econbiz.de/10011445919

Incorporating innovation subsidies in the CDM framework : empirical evidence from Belgium

Czarnitzki, Dirk; Delanote, Julie - In: Economics of innovation and new technology 26 (2017) 1/2, pp. 78-92

Persistent link: https://www.econbiz.de/10011736225

The contribution of pharmaceutical innovation to longevity growth in Germany and France

Lichtenberg, Frank R. - 2010

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

Persistent link: https://www.econbiz.de/10003977959